United Nations/Geneva: The technical advisory group of the World Health Organisation (WHO) sought “additional clarifications” from Bharat Biotech on Tuesday for its COVID-19 vaccine Covaxin to conduct a final “risk-benefit assessment” for the vaccine’s Emergency Use Listing.
The WHO technical advisory group will again meet on November 3 for a final assessment.
Covaxin manufacturer Hyderabad-based Bharat Biotech had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine’s Emergency Use Listing (EUL).
The technical advisory group met on Tuesday to review data on Covaxin for the emergency use listing.
“The TAG met today (26 October 2021) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine,” the WHO was quoted as saying by news agency PTI.
“The TAG expects to receive these clarifications from the manufacturer by the end of this week, and aims to reconvene for the final risk-benefit assessment on Wednesday, 3 November,” WHO added.
ALSO READ: Will WHO Finally Approve Covaxin Today?
Mumbai: Shreyas Iyer may be out of the Indian team currently. But the dashing right-handed…
Bhubaneswar: A rare and exquisitely crafted Filigree boat made of pure silver from Odisha were…
New Delhi/Bhubaneswar: Prime Minister Narendra Modi will participate in the ‘Odisha Parba 2024’ programme on…
New Delhi: A fresh application was filed before the Supreme Court on Sunday urging the…
Bhubaneswar: Chief Minister Mohan Majhi disbursed the first instalment of Rs 5,000 under Subhadra Yojana…
Bhubaneswar: The low-pressure over east Equatorial Indian Ocean (EIO) and adjoining southeast Bay of Bengal…
New Delhi: Cricket fans were left gasping for breath in December 2022 when Indian wicketkeeper-batter…
Puri: Repair work of Shree Jagannath temple's Ratna Bhandar in pilgrim town of Puri will…